1. Home
  2. KMT vs AGIO Comparison

KMT vs AGIO Comparison

Compare KMT & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kennametal Inc.

KMT

Kennametal Inc.

HOLD

Current Price

$29.72

Market Cap

2.2B

Sector

Industrials

ML Signal

HOLD

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$33.51

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KMT
AGIO
Founded
1938
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.3B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
KMT
AGIO
Price
$29.72
$33.51
Analyst Decision
Hold
Buy
Analyst Count
6
8
Target Price
$36.00
$38.88
AVG Volume (30 Days)
1.7M
1.1M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
2.08%
N/A
EPS Growth
268.33
N/A
EPS
4.42
N/A
Revenue
$2,356,698,000.00
$43,011,000.00
Revenue This Year
$14.24
$76.75
Revenue Next Year
$7.57
$170.73
P/E Ratio
$6.83
N/A
Revenue Growth
19.82
N/A
52 Week Low
$20.35
$22.24
52 Week High
$43.81
$46.00

Technical Indicators

Market Signals
Indicator
KMT
AGIO
Relative Strength Index (RSI) 39.57 47.79
Support Level $28.23 $26.71
Resistance Level $35.50 $36.04
Average True Range (ATR) 0.99 1.25
MACD -0.03 0.17
Stochastic Oscillator 36.20 36.97

Price Performance

Historical Comparison
KMT
AGIO

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

Share on Social Networks: